Efficacy of Adaptol and the possibility of its differential use in patients with anxiety disorders after myocardial infarction

Shilina N.N.; Statsenko M.E.; Sporova O.E.; Lempert B.A.

doi:https://doi.org/

Shilina N.N.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

Statsenko M.E.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet

ORCID: 0000-0002-3306-0312

Sporova O.E.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

Lempert B.A.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

Efficacy of Adaptol and the possibility of its differential use in patients with anxiety disorders after myocardial infarction

Authors:

Shilina N.N., Statsenko M.E., Sporova O.E., Lempert B.A.

More about the authors

Journal: Therapeutic Archive. 2013;85(9): 29‑34

Read: 11053 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Shilina NN, Statsenko ME, Sporova OE, Lempert BA. Efficacy of Adaptol and the possibility of its differential use in patients with anxiety disorders after myocardial infarction. Therapeutic Archive. 2013;85(9):29‑34. (In Russ.)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Predictors and impact of myocardial injury (VARC-3 criteria) after transcatheter aortic valve implantation. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):489-498

Impact of various rehabilitation programs on anxiety and depression after surgery of early-stage cervical cancer. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):40-44

The follow-up examination of children with breath-holding spells. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):76-80

Myocardial infarction in young age. Russian Journal of Preventive Medicine. 2024;(11):77-84

Atopic dermatitis and skin toxic reactions: comparative characteristics, psychosomatic aspects and patient management tactics. Russian Journal of Clinical Dermatology and Venereology. 2024;(6):744-752

Subjective sleep quality evaluation in patients with neuromyelitis optica spectrum disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):57-61

Comorbid anxiety disorders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment strategy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):126-136

Fibrin monomer in diagnosis of cardiovascular diseases. Russian Cardiology Bulletin. 2024;(4-2):113-120

Influence of enzymatic activity of microbiota on hemodynamics, arterial stiffness and emotional state of patients with mild-to-moderate risk of cardiovascular complications. Russian Cardiology Bulletin. 2024;(4-2):128-136

Predictors of myocardial infarction in patients with stable peripheral artery disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):61-65

Abstract:

Aim. To evaluate the efficacy and safety of adaptol in a dose of 1500-2000 mg/day in combination therapy for anxiety disorders (AD) in the early post-myocardial infarction period. Subjects and methods. The trial included 94 patients with AD who were divided into a study group of 60 patients and a control group of 34 patients. In addition to basic therapy, the study group took adaptol in a dose of 1500-200 mg/day for 30±2 days; the control group received basic therapy only. Results. The drug given in a dose of 1500-2000 mg/day in the patients with AD in the early post-myocardial infarction period was found to have high anxiolytic, autonomically normalizing, stress-protective activities and a positive effect on heart rate variability just one month after treatment. The highest efficacy of Adaptol was observed in patients with baseline hypersympathicotonic and normal autonomic responsiveness. Conclusion. Adaptol proved to be more effective in patients with baseline hypersympathicotonic and normal autonomic responsiveness, which permits the drug to be differentially used in relation to the baseline type of autonomic responsiveness.

Keywords:

adaptol

anxiety

myocardial infarction

Authors:

Shilina N.N.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

Statsenko M.E.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet

ORCID: 0000-0002-3306-0312

Sporova O.E.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

Lempert B.A.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

Close metadata

References:

Vasyuk Yu.A., Lebedev A.V., Dovzhenko T.V., Semiglazova M.V. Affektivnye rasstroistva pri ostrom infarkte miokarda i vozmozhnosti ikh korrektsii tianeptinom. Ter arkh 2010; 10: 28-33.
Tarasevich E.V. Svyaz' trevogi i depressii s obshchesomaticheskimi zabolevaniyami. Psikhiatr, psikhoter i klin psikhol 2012; 2: 123-137.
Ibrahimagic O.C., Sinanovic O., Smajlovic D. Anxiety in acute phase of ischemic stroke and myocardial infarction. Med Arh 2005; 59 (6) 366-369.
Kirichenko A.A., Ebzeeva E.Yu. Znachenie raspoznavaniya trevozhno-depressivnykh rasstroistv v klinike vnutrennikh boleznei. Consilium Medicum 2012; 5: 113-114.
Kop W.J., Stein P.K., Tracy R.P. et al. Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med 2010; 72 (7): 626-635.
Balukova E.V., Uspenskii Yu.P., Tkachenko E.I. Trevozhnye rasstroistva u bol'nykh terapevticheskogo profilya. Ter arkh 2007; 6: 85-88.
Doletskii A.A., Svet A.V., Chaplygin A.V. i dr. Psikhologicheskaya reabilitatsiya kardiologicheskikh bol'nykh. Kardiol i serdechno-sosudistaya khir 2011; 1: 31-36.
Mallik S., Spertus J.A., Reid K.J. et al. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med 2006; 166 (8): 876-883.
Nicholson A., Kuper H., Hemingway H. Depression as an aeliologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774.
Taylor D. Antidepressant drugs and cardiovascular pathology, a clinical overview of effectiveness and safety. Acta Psychiatr Scand 2008; 118: 434-442.
Manev H., Manev R. 5-lipoxygenase as a possible biological link between depressive symptoms and atherosclerosis. Arch Gen Psychiatry 2007; 64: 1333.
Slefanatou A., Kouris N.. Lekakis J. Treatment of depression in elderly patients with cardiovascular disease, research data and future prospects. Hellenic J Cardiol 2010; 51: 142-152.
Carney R., Blumenthal J., Stein P. et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2011; 104: 2024-2028.
Galyautdinova V.R., Mutalova E.G., Rustyamova Z.Ya. Depressiya u bol'nykh ishemicheskoi bolezn'yu serdtsa i ikh terapevticheskaya korrektsiya. Kardiol i serdechno-sosudistaya khir 2012; 5: 25-30.
Statsenko M.E., Rybak V.A., Govorukha O.A. Korrektsiya trevozhno-depressivnykh rasstroistv tianeptinom u bol'nykh s khronicheskoi serdechnoi nedostatochnost'yu v postinfarktnom periode. Kardiologiya 2005; 12: 48-52.
Statsenko M.E., Shilina N.N. Primenenie tsitaloprama v vosstanovitel'nom periode infarkta miokarda u patsientov s sakharnym diabetom 2 tipa i affektivnymi rasstroistvami. Ros kardiol zhurn 2008; 4: 56-60.
Statsenko M.E., Shilina N.N. Terapiya posle infarkta miokarda u patsientov s affektivnymi rasstroistvami i sakharnym diabetom tipa 2. Vrach 2012; 4: 94-98.
Chutko L.S., Rozhkova A.V., Sidorenko V.A. i dr. Generalizovannoe trevozhnoe rasstroistvo: psikhosomaticheskie podkhody k lecheniyu. Zhurn nevrol i psikhiatr 2012; 1: 40-44.
Pollack M.H. Refractory generalized anxiety disorder. J Clin Psychiatry 2009; 70: Suppl 2: 32-38.
Statsenko M.E., Sporova O.E., Govorukha O.A. i dr. Effektivnost' primeneniya fenazepama v sostave kompleksnoi terapii u bol'nykh s trevozhno-depressivnymi rasstroistvami v rannem postinfarktnom periode. Byul Volgogradskogo nauchnogo tsentra RAMN 2009; 3: 29-33.
Mkrtchyan V.R., Orlov V.A., Kozhokova L.Z. Vozmozhnosti primeneniya adaptola v klinicheskoi praktike. Kardiol i serdechno-sosudistaya khir 2012; 6: 27-32.
Statsenko M.E., Sporova O.E., Kolodyazhnaya O.I., Evtereva E.D. Effektivnost' primeneniya adaptola v kompleksnoi terapii u bol'nykh s trevozhnymi rasstroistvami v rannem postinfarktnom periode. Kardiol i serdechno-sosudistaya khir 2009; 5: 18-22.
Statsenko M.E., Sporova O.E., Shilina N.N. i dr. Terapevticheskie vozmozhnosti adaptola v rannem postinfarktnom periode u bol'nykh s trevozhnymi rasstroistvami. Kardiol i serdechno-sosudistaya khir 2011; 4: 41-47.
Petrova N., Kutuzova A., Bobrovskaya E. Medikamentoznaya korrektsiya trevozhnykh rasstroistv u bol'nykh ostrym infarktom miokarda. Vrach 2010; 7: 53-55.
Tyshchenko I.A. Osobennosti techeniya postinfarktnogo perioda u pozhilykh bol'nykh s khronicheskoi serdechnoi nedostatochnost'yu v zavisimosti ot vyrazhennosti affektivnykh rasstroistv i ikh medikamentoznoi korrektsii: Avtoref. dis. … kand. med. nauk. Volgograd 2008; 27.
Andryushchenko A.V., Drobizhev M.Yu., Dobrovol'skii A.V. Sravnitel'naya otsenka shkal CES-D, BDI i HADS (d) v diagnostike depressii v obshchemeditsinskoi praktike. Zhurn nevrol i psikhiatr 2003; 103: 11-18.
Kopina O.S. Pokazateli psikhosotsial'nogo stressa pri stenokardii i arterial'noi gipertonii. Mater. Vsesoyuz. simpoz. "Mnogofaktornaya profilaktika IBS". Tomsk 1989; 76.
Chalder T., Berelowitz G., Pawlikowska T. et. al. Development of a fatique scale. J Psychosomatic Res 1993; 37: 147-153.
Levin Ya.I., Sadykov E.T. Zolpidem v lechenii narushenii sna u bol'nykh ishemicheskim insul'tom. Zhurn nevrol i psikhiatr 2000; 3: 44-47.
Babunts I.V., Miridzhanyan E.M., Mashaekh Yu.A. Azbuka analiza variabel'nosti serdechnogo ritma. Stavropol': Printmaster 2002; 112.
Belenkov Yu.N., Mareev V.Yu. Printsipy ratsional'nogo lecheniya serdechnoi nedostatochnosti. M: Media Medika 2001; 266